Related Articles by Review for PMID: 11735619

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
1994	1
1995	1
1996	1
1997	3
1998	3
1999	3
2000	4
2001	2
2002	2
2003	5
2004	3
2005	8
2006	8
2007	6
2009	1
2010	1
2017	2
2018	1
2019	1
2021	1
2024	0

Results by year

Page 1

Potential and current use of N-methyl-D-aspartate (NMDA) receptor antagonists in diseases of aging.

Le DA, Lipton SA. Le DA, et al. Drugs Aging. 2001;18(10):717-24. doi: 10.2165/00002512-200118100-00001. Drugs Aging. 2001. PMID: 11735619 Review.

The chemical biology of clinically tolerated NMDA receptor antagonists.

Chen HS, Lipton SA. Chen HS, et al. J Neurochem. 2006 Jun;97(6):1611-26. doi: 10.1111/j.1471-4159.2006.03991.x. J Neurochem. 2006. PMID: 16805772 Free article. Review.

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data.

Parsons CG, Danysz W, Quack G. Parsons CG, et al. Neuropharmacology. 1999 Jun;38(6):735-67. doi: 10.1016/s0028-3908(99)00019-2. Neuropharmacology. 1999. PMID: 10465680 Review.

The use of NMDA-receptor antagonists in the treatment of chronic pain.

Hewitt DJ. Hewitt DJ. Clin J Pain. 2000 Jun;16(2 Suppl):S73-9. doi: 10.1097/00002508-200006001-00013. Clin J Pain. 2000. PMID: 10870744 Review.

Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults.

Lipton SA. Lipton SA. NeuroRx. 2004 Jan;1(1):101-10. doi: 10.1602/neurorx.1.1.101. NeuroRx. 2004. PMID: 15717010 Free PMC article. Review.

[New therapeutic possibilities with low-affinity NMDA receptor antagonists].

Kornhuber J, Weller M. Kornhuber J, et al. Nervenarzt. 1996 Jan;67(1):77-82. Nervenarzt. 1996. PMID: 8676993 Review. German.

The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.

Lipton SA. Lipton SA. Curr Alzheimer Res. 2005 Apr;2(2):155-65. doi: 10.2174/1567205053585846. Curr Alzheimer Res. 2005. PMID: 15974913 Review.

Competitive Gly/NMDA receptor antagonists.

Catarzi D, Colotta V, Varano F. Catarzi D, et al. Curr Top Med Chem. 2006;6(8):809-21. doi: 10.2174/156802606777057544. Curr Top Med Chem. 2006. PMID: 16719819 Review.

Mechanism of action of memantine.

Johnson JW, Kotermanski SE. Johnson JW, et al. Curr Opin Pharmacol. 2006 Feb;6(1):61-7. doi: 10.1016/j.coph.2005.09.007. Epub 2005 Dec 20. Curr Opin Pharmacol. 2006. PMID: 16368266 Review.

Glutamatergic drugs in Parkinson's disease.

Lange KW, Riederer P. Lange KW, et al. Life Sci. 1994;55(25-26):2067-75. doi: 10.1016/0024-3205(94)00387-4. Life Sci. 1994. PMID: 7997066 Review.

54 results

Page of 6

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

54 results

Results by year